Sessions Were Renumbered as of May 19.
Legend:
CC-W = McCormick Place Convention Center, West Building,
CC-N = McCormick Place Convention Center, North Building
H = Hilton Chicago,
UC = Conference Chicago at University Center
* = applied session ! = JSM meeting theme
Activity Details
380
Tue, 8/2/2016,
10:30 AM -
11:15 AM
CC-Hall F1 West
SPEED: Advances in Biopharmaceutical Research, Part 2A — Contributed Poster Presentations
Biopharmaceutical Section
Chair(s): Genevera Allen, Rice University
The oral portion will take place during Session 213148
1:
Generalizing Results from Randomized Trials to Target Population via Weighting Methods Using Propensity Score
—
Ziyue Chen, The Ohio State University ; Eloise Kaizar, The Ohio State University
2:
Bone Marrow Stromal Cell Therapy for Ischemic Stroke: A Meta-Analysis of Randomized Control Animal Trials
—
Qing Wu, Nevada Institute of Personalized Medicine ; Yuexiang Wang, Mayo Clinic ; Bart Demaerschalk, Mayo Clinic ; Saruna Ghimire, Nevada Institute of Personalized Medicine ; Kay Wellik, Mayo Clinic ; Wenchun Qu, Mayo Clinic
4:
Stepped Wedge Cluster Randomized Controlled Trials with Two Layers of Clustering: Designs and Comparisons of Power
—
Ranran Dong, The Ohio State University ; Abigail Shoben, The Ohio State University
5:
On the Use of Nonparametric Tests for Comparing Immunological Reverse Cumulative Distribution Curves (RCDCs)
—
Lihan Yan, FDA ; Bob Small, Sanofi Pasteur ; Ayca Ozol-Godfrey, Sunovion Pharmaceuticals
7:
Impact of Mis-Specified Prior on the Bayesian Dose-Finding Method in Phase I Cancer Trials
—
Lixia Pei, Janssen R&D ; Kevin Liu, Janssen R&D ; Hong Tian, Janssen R&D
8:
Covariate Adjustment for Logistic Regression Analysis of Binary Clinical Trial Data
—
Honghua Jiang ; Pandurang Kulkarni, Eli Lilly and Company ; Craig Mallinckrodt, Eli Lilly and Company ; Linda Shurzinske, Eli Lilly and Company ; Geert Molenberghs, Universiteit Hasselt ; Ilya Lipkovich, Quintiles
9:
Improving Vaccine Inventory Utilization Using R-Based Statistical Heuristic Algorithm
—
Hesham Fahmy, Merck
10:
Value-Driven Decision Making at Late Stage of Drug Development: Statistical Simulation Approach
—
Masanori Ito, Astellas Pharma ; Hideki Hirooka, Astellas Pharma
